XML 126 R97.htm IDEA: XBRL DOCUMENT
v3.23.4

Stockholders' Equity (Details) |  |  |  |  |  |  | 1 Months Ended | 3 Months Ended | 9 Months Ended | 12 Months Ended |  |  |  |
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Oct. 05, 2023 shares | Sep. 26, 2023 $ / shares shares | Jun. 09, 2023 USD ($) $ / shares | Jun. 06, 2023 $ / shares shares | Feb. 16, 2023 USD ($) $ / shares shares | Jul. 13, 2021 $ / shares shares | Sep. 30, 2023 USD ($) Vote $ / shares shares | Jun. 30, 2023 $ / shares shares | May 31, 2023 USD ($) shares | Apr. 30, 2023 USD ($) shares | Sep. 30, 2023 USD ($) Vote $ / shares shares | Jun. 30, 2023 $ / shares shares | Sep. 30, 2023 USD ($) Vote $ / shares shares | Dec. 31, 2022 USD ($) $ / shares shares | Dec. 31, 2021 USD ($) $ / shares shares | Dec. 31, 2018 item shares | Jun. 08, 2023 $ / shares shares | Feb. 28, 2023 $ / shares shares | Dec. 16, 2022 $ / shares shares | Apr. 27, 2021 $ / shares shares
Stockholders' Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Maximum number of shares which the Company is authorized to issue |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 300,000,000
Preferred stock, par value (in dollars per share) | $ / shares |  |  |  |  |  |  | $ 0.0001 |  |  |  | $ 0.0001 |  | $ 0.0001 | $ 0.0001 | $ 0.0001 |  |  |  |  | $ 0.0001
Accumulated restricted common stock outstanding |  |  |  |  |  |  | 10,687,724 |  |  |  | 10,687,724 |  | 10,687,724 | 648,862 |  |  |  |  |  |
Accumulated restricted common stock issued |  |  |  |  |  |  | 10,687,724 |  |  |  | 10,687,724 |  | 10,687,724 | 648,862 |  |  |  |  |  |
Preferred stock, shares issued |  |  |  |  |  |  | 0 |  |  |  | 0 |  | 0 | 0 | 0 |  |  |  |  |
Net proceeds from sales of common stock | $ |  |  |  |  |  |  |  |  |  |  |  |  | $ 14,931,171 | $ 1,300,000 |  |  |  |  |  |
Number of warrants purchased |  |  |  |  |  | 199,241 | 15,625 |  |  |  | 15,625 |  | 15,625 |  |  |  |  | 9,962 |  |
Term of warrants |  |  |  |  |  | 5 years | 5 years |  |  |  | 5 years |  | 5 years |  |  |  |  | 5 years |  |
Sale of stock exercise price | $ / shares |  |  |  |  |  | $ 0.65875 |  |  |  |  |  |  |  |  |  |  |  | $ 13.175 |  |
Issuances of common stock, net (in shares) |  |  |  |  |  | 7,187,500 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price | $ / shares |  |  |  |  |  | $ 100.00 | $ 100.00 |  |  |  | $ 100.00 |  | $ 100.00 |  |  |  |  |  |  |
Restricted shares issued in exchange for subscriptions receivable |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 292,250 |  |  |  |
Number of purchasers for restricted shares in exchange for subscriptions receivable | item |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2 |  |  |  |
Interest rate for subscriptions receivable |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 4.00% |  |  |  |
Common Stock - Dividends and Voting |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash dividends were declared or paid | $ |  |  |  |  |  |  |  |  |  |  | $ 0 |  | $ 0 | $ 0 | $ 0 |  |  |  |  |
Common stock voting rights per share |  |  |  |  |  |  | 1 |  |  |  | 1 |  | 1 | 1 |  |  |  |  |  |
Maximum |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price | $ / shares |  |  |  |  |  |  | $ 0.6375 |  |  |  | $ 0.6375 |  | $ 0.6375 |  |  |  |  |  |  |
Pre-funded warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Price per share (in dollars per share) | $ / shares |  |  |  | $ 3.49 |  |  | 0.50 | $ 3.49 |  |  | 0.50 | $ 3.49 | $ 0.50 |  |  |  |  |  |  |
Issuances of common stock, net (in shares) |  |  |  |  |  |  |  | 1,901,000 |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants sold |  |  |  |  |  |  |  |  |  |  |  |  | 16,163,000 |  |  |  |  |  |  |
Exercise price | $ / shares |  |  |  |  |  |  | $ 0.01 | $ 0.01 |  |  | $ 0.01 | $ 0.01 | $ 0.01 |  |  |  |  |  |  |
Series A warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Term of warrants |  |  | 3 years |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price | $ / shares |  |  | $ 3.25 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Series A-1 Warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants purchased |  |  |  |  |  |  | 2,000,000 | 2,000,000 |  |  | 2,000,000 | 2,000,000 | 2,000,000 |  |  |  |  |  |  |
Exercise price | $ / shares |  |  |  |  |  |  | $ 3.25 |  |  |  | $ 3.25 |  | $ 3.25 |  |  |  |  |  |  |
Series A-2 Warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants purchased |  |  |  |  |  |  | 2,000,000 | 2,000,000 |  |  | 2,000,000 | 2,000,000 | 2,000,000 |  |  |  |  |  |  |
Exercise price | $ / shares |  |  |  |  |  |  | $ 3.25 |  |  |  | $ 3.25 |  | $ 3.25 |  |  |  |  |  |  |
June Placement Agent Warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants purchased |  |  |  |  |  |  | 140,000 |  |  |  | 140,000 |  | 140,000 |  |  |  | 140,000 |  |  |
Term of warrants |  |  | 3 years |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price | $ / shares |  |  |  |  |  |  | $ 4.38 |  |  |  | $ 4.38 |  | $ 4.38 |  |  |  | $ 4.375 |  |  |
Underwriter Warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants purchased | 16,696 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Underwriter Warrants | Maximum |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants purchased |  |  |  |  |  |  | 843,150 |  |  |  | 843,150 |  | 843,150 |  |  |  |  |  |  |
Term of warrants |  |  |  |  |  |  | 5 years |  |  |  | 5 years |  | 5 years |  |  |  |  |  |  |
Commencement period for exercise of warrants, following the date of issuance |  |  |  |  |  |  |  |  |  |  |  |  | 180 days |  |  |  |  |  |  |
RDO PFW |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Price per share (in dollars per share) | $ / shares |  |  |  | 0.01 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
White Lion Purchase Agreement |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net proceeds from sales of common stock | $ |  |  |  |  |  |  |  |  | $ 518,844 | $ 518,844 |  |  |  |  |  |  |  |  |  |
Issuances of common stock, net (in shares) |  |  |  |  |  |  |  |  | 110,000 | 110,000 |  |  |  |  |  |  |  |  |  |
Aggregate legal and printing expenses | $ |  |  |  |  |  |  |  |  | $ 75,418 | $ 75,418 |  |  |  |  |  |  |  |  |  |
Securities Purchase Agreement |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Price per share (in dollars per share) | $ / shares |  |  |  | $ 3.50 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuances of common stock, net (in shares) |  |  |  | 99,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net proceeds | $ |  |  | $ 6,100,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Commencement period for exercise of warrants, following the date of issuance |  |  |  |  | 6 months |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Securities Purchase Agreement | Pre-funded warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants sold |  |  |  | 1,901,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Securities Purchase Agreement | Series A-1 Warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants sold |  |  |  | 2,000,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Securities Purchase Agreement | Series A-2 Warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants sold |  |  |  | 2,000,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Securities Purchase Agreement | June Placement Agent Warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants purchased |  |  |  |  |  |  |  | 140,000 |  |  |  | 140,000 |  |  |  |  |  |  |  |
Term of warrants |  |  |  |  |  |  |  | 3 years |  |  |  | 3 years |  |  |  |  |  |  |  |
Exercise price | $ / shares |  |  |  |  |  |  |  | $ 4.375 |  |  |  | $ 4.375 |  |  |  |  |  |  |  |
Over-Allotment Option |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuances of common stock, net (in shares) | 333,922 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Securities Purchase Agreement |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Aggregate of direct offering |  |  |  |  | 142,315 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Price per share (in dollars per share) | $ / shares |  |  |  |  | $ 10.54 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net proceeds from sales of common stock | $ |  |  |  |  | $ 1,200,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants purchased |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 199,241 |
Term of warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 5 years |
Sale of stock exercise price | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 0.65875 |
Underwriting Agreement |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Price per share (in dollars per share) | $ / shares |  | $ 0.51 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuances of common stock, net (in shares) |  | 700,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net proceeds | $ |  |  |  |  |  |  | $ 7,000,000.0 |  |  |  |  |  |  |  |  |  |  |  |  |
Underwriting Agreement | Pre-funded warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Price per share (in dollars per share) | $ / shares |  | $ 0.50 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants exercised |  |  |  |  |  |  | 7,087,050 |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants sold |  | 16,163,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Underwriting Agreement | Pre-funded warrants | Maximum |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants purchased |  | 2,339,200 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Underwriting Agreement | Underwriter Warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Term of warrants |  |  |  |  |  |  | 5 years |  |  |  | 5 years |  | 5 years |  |  |  |  |  |  |
Exercise price | $ / shares |  |  |  |  |  |  | $ 0.6375 |  |  |  | $ 0.6375 |  | $ 0.6375 |  |  |  |  |  |  |
Commencement period for exercise of warrants, following the date of issuance |  |  |  |  |  |  | 180 days |  |  |  |  |  |  |  |  |  |  |  |  |
Underwriting Agreement | Underwriter Warrants | Maximum |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants purchased |  |  |  |  |  |  | 843,150 |  |  |  | 843,150 |  | 843,150 |  |  |  |  |  |  |
Common Stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Maximum number of shares which the Company is authorized to issue |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 290,000,000
Issuances of common stock, net (in shares) |  |  |  |  |  |  |  |  |  |  | 8,737,050 | 1,159,497 |  |  | 7,187,500 |  |  |  |  |
Preferred Stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Maximum number of shares which the Company is authorized to issue |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 10,000,000

X
- Definition Accumulated restricted common stock issued. + References No definition available. + Details
Name: | rnaz_AccumulatedRestrictedCommonStockIssued
Namespace Prefix: | rnaz_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Accumulated restricted common stock outstanding. + References No definition available. + Details
Name: | rnaz_AccumulatedRestrictedCommonStockOutstanding
Namespace Prefix: | rnaz_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of exercise price of class of warrant or right number of securities called by warrants. + References No definition available. + Details
Name: | rnaz_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsExercised
Namespace Prefix: | rnaz_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of warrants or rights issued during the period. + References No definition available. + Details
Name: | rnaz_ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued
Namespace Prefix: | rnaz_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of votes that each common share is entitled. + References No definition available. + Details
Name: | rnaz_CommonStockNumberOfVotesPerShare
Namespace Prefix: | rnaz_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Interest rate for subscriptions receivable. + References No definition available. + Details
Name: | rnaz_InterestRateForSubscriptionsReceivable
Namespace Prefix: | rnaz_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Maximum number of shares which the Company is authorized to issue. + References No definition available. + Details
Name: | rnaz_MaximumNumberOfSharesWhichCompanyIsAuthorizedToIssue
Namespace Prefix: | rnaz_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of purchasers for restricted shares in exchange for subscriptions receivable + References No definition available. + Details
Name: | rnaz_NumberOfPurchasersForRestrictedSharesInExchangeForSubscriptionsReceivable
Namespace Prefix: | rnaz_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Restricted shares issued in exchange for subscriptions receivable. + References No definition available. + Details
Name: | rnaz_RestrictedSharesIssuedInExchangeForSubscriptionsReceivable
Namespace Prefix: | rnaz_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Commencement period for exercise of warrants, following the date of issuance of such warrants. + References No definition available. + Details
Name: | rnaz_WarrantsAndRightsExercisableCommencementPeriodForExerciseOfWarrants
Namespace Prefix: | rnaz_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13 Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef -Topic 272 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483014/272-10-45-3 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 272 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482987/272-10-50-1 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(d)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(27)(b)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(i)(2)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(i)(1)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(i)(2)(i)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(i)(2)(ii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3 + Details
Name: | us-gaap_ClassOfStockLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Exercise price per share or per unit of warrants or rights outstanding. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- References No definition available. + Details
Name: | us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 2 -SubTopic 405 -Topic 942 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481071/942-405-45-2 + Details
Name: | us-gaap_DividendsCommonStock
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash outflow for cost incurred directly with the issuance of an equity security. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 15 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15 + Details
Name: | us-gaap_PaymentsOfStockIssuanceCosts
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_PreferredStockParOrStatedValuePerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_PreferredStockSharesIssued
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The cash inflow from the additional capital contribution to the entity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 14 -Subparagraph (a) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14 + Details
Name: | us-gaap_ProceedsFromIssuanceOfCommonStock
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 14 -Subparagraph (a) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(i)(1)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3 + Details
Name: | us-gaap_ProceedsFromIssuanceOrSaleOfEquity
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. + References No definition available. + Details
Name: | us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. + References No definition available. + Details
Name: | us-gaap_SaleOfStockPricePerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Per share or per unit amount of equity securities issued. + References No definition available. + Details
Name: | us-gaap_SharesIssuedPricePerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of new stock issued during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(4)(b)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(i)(1)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1 Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesNewIssues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_WarrantsAndRightsOutstandingTerm
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=rnaz_PreFundedWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=rnaz_SeriesaWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=rnaz_Seriesa1WarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=rnaz_Seriesa2WarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=rnaz_JunePlacementAgentWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=rnaz_UnderwriterWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=rnaz_RegisteredDirectOfferingPreFundedWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=rnaz_WhiteLionPurchaseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=rnaz_SecuritiesPurchaseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=rnaz_SecuritiesPurchaseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=rnaz_UnderwritingAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |